|Bid||69.00 x 800|
|Ask||74.00 x 900|
|Day's Range||69.89 - 70.60|
|52 Week Range||60.42 - 82.27|
|Beta (3Y Monthly)||1.33|
|PE Ratio (TTM)||20.42|
|Earnings Date||Aug 12, 2019 - Aug 16, 2019|
|Forward Dividend & Yield||0.66 (0.98%)|
|1y Target Est||83.69|
Agilent Technologies Inc. (NYSE:A) today announced the opening of a production facility in Colorado that more than doubles its capacity to develop and manufacture “oligos,” which are short DNA and RNA molecules that customers use to produce nucleic acid-based therapeutics. Agilent expects the demand for therapeutic oligo manufacturing to grow near 10% each year through 2025, to over $750 million by 2025. This facility will enable Agilent to meet this growing demand and to continue being a partner of choice to pharmaceutical and biotech companies.
Mike McMullen has been the CEO of Agilent Technologies, Inc. (NYSE:A) since 2015. This report will, first, examine the...
Large Bay Area tech employers that pay a typical employee more than $200,000 per year include the typical suspects like Google parent Alphabet Inc., Facebook and Netflix. But several companies that are lesser-known outside Silicon Valley also pay top dollar for talent.
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don't publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That's why we analyze the […]
PD-L1 IHC 22C3 pharmDx can now be used as an aid to identify HNSCC patients for treatment with KEYTRUDA®
Artisan Partners Asset Management APAM has long earned Morningstar's admiration. As a result, Artisan has earned a Positive Parent rating, one of the pillars that support Morningstar Medalist designations for a number of Artisan funds. Of the 15 open-end strategies Artisan offers, 12 are on Morningstar's coverage list, and all of those have earned Morningstar Analyst Ratings of Bronze, Silver, or Gold.
Agilent Technologies Inc. (NYSE:A) announced today the results of its first Pharma Lab Leaders Survey looking to gather insights from pharmaceutical, biopharmaceutical, and contract research laboratories in seven countries around the world. Respondents included 650 laboratory managers, directors, and supervisors from China, Germany, India, South Korea, Switzerland, Austria, and the United States. “We were extremely pleased that Agilent wanted to work with us again to explore the challenges and opportunities within this unique group of laboratories,” said Paljit Sohal, principal consultant, of Frost & Sullivan.
Agilent Technologies Inc. (NYSE:A) introduced the newest member of its LC/MS portfolio today at the American Society for Mass Spectrometry Conference (ASMS) which is being held June 2 through June 6 in Atlanta, Georgia. The new Agilent InfinityLab LC/MSD iQ System incorporates ‘designed-in’ smart features, software, and hardware developed specifically for chemists and chromatographers who will benefit from the intuitive design and greater level of detail generated by a mass selective detector. An early maintenance feedback feature allows lab managers to plan routine maintenance on the lab’s schedule resulting in a focus on overall productivity.
The United States traditionally has lagged behind other countries in regulating individual privacy rights in personal information. Now, California has enacted arguably the most comprehensive data privacy statute in the country. The California Consumer Privacy Act of 2018 will go into effect Jan. 1, 2020, establishing comprehensive privacy rights for California residents (called “consumers” in the CCPA) over personal information collected, used, and sold by businesses.
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Agilent Technologies, Inc. (NYSE:A) today announced that a quarterly dividend of 16.4 cents per share of common stock will be paid on July 24, 2019, to all shareholders of record as of the close of business on July 2, 2019. Agilent Technologies Inc. (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions.
Assessing Agilent Technologies after Its Second-Quarter Release(Continued from Prior Part)Revenue trendsAgilent Technologies (A) expects its ACG (Agilent CrossLab Group) and DGG (Diagnostics and Genomics Group) revenue momentum to be similar in
Assessing Agilent Technologies after Its Second-Quarter Release(Continued from Prior Part)Revenue by segmentIn the second quarter, Agilent Technologies’ (A) LSAG (Life Sciences and Applied Markets Group) core revenue fell 1% YoY (year-over-year)
Assessing Agilent Technologies after Its Second-Quarter Release(Continued from Prior Part)Cash flow and cash asset guidanceAgilent Technologies (A) has reduced its CFO (cash flow from operations) guidance from $1,100 million–$1,150 million to
Assessing Agilent Technologies after Its Second-Quarter Release(Continued from Prior Part)Margin estimatesAgilent Technologies’ (A) gross margin expanded by 56 basis points YoY (year-over-year) to 56% in the second quarter, driven by higher
Assessing Agilent Technologies after Its Second-Quarter Release(Continued from Prior Part)EPS guidanceAgilent Technologies (A) has reiterated its fiscal 2019 non-GAAP EPS guidance of $3.03–$3.07, which represents a rise of 8.6%–10.0% YoY
RESEARCH REPORTS These reports, excerpted and edited by Barron’s, were issued recently by investment and research firms. The reports are a sampling of analysts’ thinking; they should not be considered the views or recommendations of Barron’s.
Assessing Agilent Technologies after Its Second-Quarter Release(Continued from Prior Part)Revenue guidanceIn its second-quarter investor presentation, Agilent Technologies (A) reduced its fiscal 2019 revenue guidance from 5.15 billion–$5.19
Assessing Agilent Technologies after Its Second-Quarter ReleaseStock price movementsOn May 14, Agilent Technologies (A) reported its second-quarter results. Its revenue rose 2.65% YoY (year-over-year) on a reported basis to $1.24 billion, missing
Danaher might be experiencing buyer’s remorse after GE biopharma competitors posted weak results. The purchase agreement might make remorse moot.